K-877-ER
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for K-877-ER, covering 2023-12-22 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis [Phase 2]